GlucoTrack, Inc. (GCTK)
OTCMKTS · Delayed Price · Currency is USD
1.390
-0.660 (-32.20%)
At close: Oct 29, 2026
GlucoTrack Company Description
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.
The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
GlucoTrack, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Erik Emerson |
Contact Details
Address: 301 Route 17 North Rutherford, New Jersey 07070 United States | |
| Phone | 201 842 7715 |
| Website | glucotrack.com |
Stock Details
| Ticker Symbol | GCTK |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US45824Q8794 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Erik C. Emerson | Chief Executive Officer and Director |
| Dr. Paul V. Goode Ph.D. | Chief Technical Officer and President |
| Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus and Consultant |
| David Malka BA | Co-Founder |
| Vincent Wong | Chief Operations Officer |
| Dr. Mark Tapsak Ph.D. | Chief Scientific Officer |
| Drinda Benjamin | Chief Commercial Officer |